FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE) announced its financial results for December 31, 2006. Revenue for the three months ended December 31, 2006, was $3,415,000 compared to $1,600,000 for the three months ended December 31, 2005, and $6,059,000 for the year ended December 31, 2006, compared to $14,276,000 for the year ended December 31, 2005. Revenue for all periods is primarily due to Fortical. Revenue from Fortical sales and royalties were $3,217,000 for the three months ended December 31, 2006, $1,510,000 for the three months ended September 30, 2006; $348,000 for the three months ended June 30, 2006 and $197,000 for the three months ended March 31, 2006.
